Imagenomix delivers rapid and affordable cancer diagnostic results through advanced AI capabilities so patients receive effective, targeted treatments for their specific cancer type.

Case 45 is building the most advanced precision AI model for oncology, rooted in cancer evolutionary biology. They are targeting healthcare (oncology prognostic and predictive tests in unmet need), and pharma (drug development) business models.